Fundz

Fundz Deep Dive

Everything you need to win Tiziana Life Sciences — in one platform.

Who to reach, what to say, and why now on Tiziana Life Sciences — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Tiziana Life Sciences — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Tiziana Life Sciences Announces Registered Direct Offering for Development of Immunomodulation Therapies

Oct 31, 2024•over 1 year ago

Contract Type

partnership

LondonBiotechnologyHealth Care

Description

Tiziana Life Sciences, Ltd. announced a registered direct offering of approximately $10 million. The net proceeds from the offering will be used for the company's Phase 2a clinical trial, clinical development of foralumab in Alzheimer’s disease, developing foralumab for other indications, and for working capital and other general corporate purposes.

Company Information

Company

Tiziana Life Sciences

Location

London, England, United Kingdom

About

Tiziana Life Sciences LTD is a biotechnology company focused on transformational technology enabling alternative routes for immunotherapy .

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Tiziana Life Sciences's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.